News-Medical.Net on MSN
Harnessing AI to optimize the development of new protein manufacturing processes
Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new study, MIT chemical engineers have harnessed artificial ...
Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...
The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...
Gas vesicles are among the largest known protein nanostructures produced and assembled inside microbial cells. These hollow, ...
The demand for complex therapeutic proteins, is rapidly accelerating, with the bispecific market alone projected to grow from $12B in 2024 to $50B by 2030. While these atypical molecules offer ...
MIT’s AI system boosts precision protein drug production, cutting development costs by learning the “language” of genetic sequences.
Researchers at Baylor College of Medicine and collaborating institutions have discovered that a protein called hnRNPM helps protect the integrity of the process cells use to make proteins. The protein ...
Plant cell-based bioproduction systems are known for producing proteins with proper folding and post-translational modifications that have been used in a handful of approved therapeutics. Widespread ...
It had been thought that AI would play a big part in digital-only domains like math and coding, but cleverly connecting these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results